The pharmaceutical industry faces mounting pressure to address neglected tropical diseases, with tuberculous meningitis (TBM) representing a particularly challenging yet underserved market segment. This comprehensive assessment examines investment opportunities, market barriers, and strategic considerations for stakeholders interested in advancing therapeutic solutions for this...